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50% of the patients have an aggravated hereditary anamnesis. We studied the genealogical 
trees of the patients; we found out that: in 25 families of 2 and more relatives (gr.l and ll) with 
cancer (thyroid, colorectal, breast, ovarian, malignant melanoma cancer) and thyroid nodular 
pathology.  
Conclusions. From the point of view of molecular and genetic side, PTC is heterogeneously 
and it needs new approaches of genetic modifications in clinical practices. The proportion of 
patients with cancer is increasing with age, aggravated hereditary and personal anamnesis. It is 
necessary to introduce screening by genetic exam for high-risk patients.  
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Introduction. The increasing number of multidrug-resistant bacteria in the last decade has left 
clinicians with very few medication options, usually resulting in the use of more expensive 
treatments. The demand of new therapeutic approaches encourages the discovery of new 
natural products with possible antimicrobial activity.  
Aim of the study. Therefore, the aim of this study was to look for active substances that could 
be used as antibacterial agents. To achieve this objective, two different fractions 
(myxoxantophyll and phycocyanin) from Spirulina platensis were investigated. 
Myxoxanthophyll is a carotenoid glycoside yellowish pigment present in the photosynthetic 
apparatus of Arthrospira (Spirulina) platensis and phycocyanin is a protein complex, accessory 
pigment to chlorophyll also present in Spirulina platensis.  
Materials and methods. The cyanobacteria extracts were tested in vitro for their antibacterial 
proprieties against (Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella 
pneumoniae, Staphylococcus aureus and coagulase-negative staphylococci) using macro 
dilution method Ericsson and Sheris. The Time-kill kinetics assay (CLSI M26) was used to 
study the bactericidal activity of the Spirulina platensis extracts against bacterial strains over 
the time.  
Results. By means of the broth macro dilution assay, it was found that microalga extracts 
possess pronounced antibacterial activity against Acinetobacter baumannii (MIC: 0,0275 
mg/ml for myxoxanthophyll and 0,18 mg/ml for phycocyanin). In the case of coagulase-
negative staphylococci the antimicrobial activity of Arthrospira platensis fractions was low. 
Gram-negative bacteria showed to be more sensitive to the action Spirulina platensis pigments 
than Gram-positive bacteria. Also, it was found that myxoxanthophyll possess bacteriostatic 
and bactericidal action at a lower concentration than the phycocyanin. At a concentration of 
0,04 mg/ml myxoxantophyll could kill 100% bacteria in approximately 4 hours, and the time-
kill for phycocyanin was about 8 hours at the concentration 0,72 mg/ml.  
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Conclusions. Further in vivo studies are required to investigate Spirulina platensis fractions 
potential toxic effects. In particular researches are needed to evaluate the use of control-release 
formulations in order to maintain the Arthrospira platensis pigments concentrations at 
antibacterial active doses.  
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Introduction. IFNs are a class of soluble glycoproteins with a strong antiviral activity, 
classified into three types: Type I (IFN-α/β), II (IFN-γ) and III (IFN-λ). Because of the clinical 
failures using only antiviral medications and the generation of drug-resistant strains, IFN 
treatment became a good option because it targets the host's immune response and not the 
specific viral proteins.  
Aim of the study. Study and analysis of existing data in the literature on antiviral activities of 
IFN and their use in antiviral therapy in human diseases.  
Materials and methods. The presentation represents a literature review based on previously 
completed research into the role of IFN in the treatment of viral diseases.  
Results. Because of their ability to modulate immune responses, IFNs have become attractive 
therapeutic options in controlling chronic viral infections. Type I IFNs were part of standard 
treatment for VHC and VHB infections and no IFN-resistant viral subpopulations were 
observed. In addition, there is an increased interest in testing the antiviral efficacy of type III 
IFN in HCV infection, based on the fact that the type III IFN receptor is more restricted in its 
expression and is present on the hepatocytes. IFN-γ combined with highly active antiretroviral 
therapy (HAART) dramatically reduced morbidity and mortality associated with HIV, being 
used successfully in treating opportunistic infections associated with HIV.  
Conclusions. Although they are effective, IFNs need to be used with caution, because they are 
powerful cytokines that affect a wide range of cells; as a result, patients usually had side effects 
and a part of them had systemic effects.  
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Introduction. More than half of the adult global population are carriers of H.pylori, a Gram-
negative microaerobic human pathogen, which is associated with various gastroduodenal 
diseases. Diagnostic tests are divided into noninvasive (UBT, SAT, serology) and invasive 
